J. Coste

发表

Comparison of two innovatives approaches for bacterial detection: paramagnetic nanoparticles and self-assembled multilayer processes

Nicole Jaffrezic-Renault, Walid Mohamed Hassen, Chantal Fournier-Wirth, 2008 .

Nanotechnologies for pathogen detection: Future alternatives?

C. Fournier-Wirth, J. Coste, 2010, Biologicals : journal of the International Association of Biological Standardization.

Label-free detection of bacteria by electrochemical impedance spectroscopy: comparison to surface plasmon resonance.

Nicole Jaffrezic-Renault, Abdelhamid Errachid, Jean-Pierre Cloarec, 2007, Analytical chemistry.

An innovative biologic recycling process of leukoreduction filters to produce active human antimicrobial peptides

S. Lehmann, K. Brodolin, C. Fournier-Wirth, 2014, Transfusion.

Evaluation of the enhanced bacterial detection system for screening of contaminated platelets

M. Deschaseaux, P. Morel, C. Fournier-Wirth, 2006, Transfusion.

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

J. Pawlotsky, D. Dhumeaux, J. Coste, 2002, Journal of Virology.

In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus.

C. Sureau, J. Coste, P. Maurel, 1998, The Journal of general virology.

Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.

P. Marcellin, J. Pawlotsky, F. Roudot-thoraval, 1999, Journal of viral hepatitis.

Advances in transfusion medicine in the first decade of the 21st century: Advances in miniaturized technologies.

C. Fournier-Wirth, J. Coste, J. Petrik, 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Sicca syndrome associated with hepatitis C virus infection.

C. Bologna, P. Perney, J. Coste, 1996, Arthritis and rheumatism.

Neurological Complications of Varicella-zoster Virus Infection in Adults with Human Immunodeficiency Virus Infection

P. Lebon, F. Rozenberg, J. Coste, 2000, Scandinavian journal of infectious diseases.

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

D. Harats, F. Malavasi, C. Fournier-Wirth, 2007, Journal of hepatology.

Impact of Leucocyte Depletion and Prion Reduction Filters on TSE Blood Borne Transmission

O. Andréoletti, S. Simon, C. Lacroux, 2012, PloS one.

Plasminogen-Based Capture Combined with Amplification Technology for the Detection of PrPTSE in the Pre-Clinical Phase of Infection

M. Moudjou, H. Laude, V. Béringue, 2013, PloS one.

Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep

S. Y. Kim, S. An, T. Yokoyama, 2015, International journal of nanomedicine.

A report on transmissible spongiform encephalopathies and transfusion safety

C. Prowse, J. Coste, R. Eglin, 2009, Vox sanguinis.

Preclinical sporadic Creutzfeldt‐Jakob disease in French blood donors: an epidemiologic model‐based study

I. Capek, V. Vaillant, A. Alpérovitch, 2012, Transfusion.

Symposium on prions and transfusion safety.

J. Coste, 2013, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Prion reduction of red‐blood‐cells

C. Prowse, M. Turner, P. Tiberghien, 2012, Vox sanguinis.

Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples

P. Morel, J. Cazenave, J. Coste, 2010, Transfusion.

An overview of the diagnostic tools.

J. Coste, 2013, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Microconductometric Detection of Bacterial Contamination

Jana Krej, N. Jaffrezic‐Renault, A. Errachid, 2014 .

GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum

P. Marcellin, J. Pawlotsky, F. Roudot-thoraval, 1997, Journal of clinical microbiology.

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003

Indira Hewlett, Ludo Muylle, Susan L. Stramer, 2005 .

Screening blood donations for viral genomes: multicenter study of real‐ time simulation using pooled samples on the model of hepatitis C virus RNA detection

J. Pawlotsky, B. Mercier, P. Rouger, 1998, Transfusion.

The Seroepidemiology of Human T-Lymphotropic Viruses: Types I and II in Europe: A Prospective Study of Pregnant Women

G. Pauli, A. Ades, V. Soriano, 2005, Journal of acquired immune deficiency syndromes.

HTLV-I/II antibodies in French blood donors

J. Coste, F. Barin, A. Couroucé, 1990, The Lancet.

[Detection of visna-maedi virus antibodies and antigens by immunoblotting].

J. Coste, J. Nicolas, M. Rucheton, 1989, Annales de recherches veterinaires. Annals of veterinary research.

Microconductometric immunosensor for label-free and sensitive detection of Gram-negative bacteria.

Nicole Jaffrezic-Renault, Abdelhamid Errachid, Fanny Leon, 2014, Biosensors & bioelectronics.

HCV RNA in blood donors with isolated reactivities by third‐generation RIBA

V. Barlet, J. Coste, F. Barin, 2000, Transfusion.

Efficiencies of Four Versions of the AMPLICOR HIV-1 MONITOR Test for Quantification of Different Subtypes of Human Immunodeficiency Virus Type 1

M. Peeters, E. Delaporte, J. Coste, 1999, Journal of Clinical Microbiology.

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

J. Dubuisson, J. Pascussi, J. McKeating, 2007, Journal of Virology.

Use of serial analysis of gene expression (SAGE) technology reveals new granulocytic markers.

T. Commes, J. Coste, J. Schved, 2004, Journal of immunological methods.

Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease

J. Laplanche, H. Fleury, P. Tiberghien, 2016, Science Translational Medicine.

Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma

M. Peeters, E. Delaporte, J. Coste, 1996, Journal of medical virology.

[IgG autoantibodies against cellular p72 antigen crossing with (MLV) p15-gag antigen: presence in early HIV 1 infection, in HBV infection and in primary Gougerot-Sjögren].

J. Coste, J. Reynes, I. Lamaury, 1992, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Prevalence of GBV C/HGV RNA and GBV C/HGV Antibodies in French Volunteer Blood Donors: Results of a Collaborative Study

P. de Micco, D. Ouzan, R. Césaire, 1999, Vox Sanguinis.

Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy

P. Marcellin, J. Pawlotsky, F. Roudot-thoraval, 1999, Journal of viral hepatitis.

[Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients].

C. Guérin, J. Coste, I. Gorin, 2000, Annales de medecine interne.

Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T‐lymphotropic virus infection in French blood donors

J. Coste, A. Couroucé, C. Defer, 1995, Transfusion.

Detection of blood‐transmissible agents: can screening be miniaturized?

N. Jaffrezic‐Renault, C. Fournier-Wirth, J. Coste, 2010, Transfusion.

Detection of HIV–1 RNA in Two Consecutive Blood Donations Screened Negative for HIV Antibodies

F. Bibollet-Ruche, J. Coste, A. Guillard, 1998, Vox Sanguinis.

Rapid and Highly Sensitive Detection of Variant Creutzfeldt - Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies

V. Béringue, S. Lehmann, J. Coste, 2016, PloS one.

Prion Protein Expression and Processing in Human Mononuclear Cells: The Impact of the Codon 129 Prion Gene Polymorphism

S. Lehmann, J. Coste, C. Segarra, 2009, PloS one.

Identification of apolipoprotein C‐III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection

D. Missé, C. Bonfils, F. Veas, 2008, Proteomics. Clinical applications.

Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. Retrovirus Study Group of the French Society of Blood Transfusion.

J. Coste, A. Couroucé, M. Canavaggio, 1993, AIDS.

Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France

J. Coste, A. Couroucé, I. Lemaire, 1993 .

GB virus type C/hepatitis G virus infection in French blood donors with anti‐NS5 isolated reactivities by recombinant immunoblot assay for hepatitis C virus

J. Coste, S. Laperche, A. Couroucé, 1999, Transfusion.

Effect of HIV-1 genetic diversity on HIV-1 RNA quantification in plasma: comparative evaluation of three commercial assays.

M. Peeters, E. Delaporte, J. Coste, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Acute HCV infection detected in a blood donor by NAT

J. Izopet, J. Coste, J. Schved, 2003, Transfusion.

[Application of molecular biology to blood transfusion safety: the nucleic acid testing].

V. Barlet, J. Coste, S. Laperche, 2003, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Sensitivity of HCV RNA and HIV RNA blood screening assays

J. Viret, J. Coste, C. Hyland, 2002, Transfusion.